Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy

Name: Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy
License: Public Domain

M.D. Anderson Cancer Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

edema, erythema, estrogen receptor negative, her2/neu negative, peau d'orange, progesterone receptor negative

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 390915
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.